California Public Employees Retirement System Adverum Biotechnologies, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.36 - $10.56 $593,712 - $1.87 Million	-176,700 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$9.84 - $14.26 $237,203 - $343,751	-24,106 Reduced 12.0%	176,700 $1.92 Million
Q3 2020 Nov 05, 2020	BUY	$10.3 - $21.64 $361,457 - $759,412	35,093 Added 21.18%	200,806 $2.07 Million
Q2 2020 Aug 12, 2020	BUY	$8.53 - $25.64 $334,862 - $1.01 Million	39,257 Added 31.04%	165,713 $3.46 Million
Q1 2020 May 12, 2020	BUY	$7.98 - $16.32 $19,950 - $40,800	2,500 Added 2.02%	126,456 $1.24 Million
Q4 2019 Jan 27, 2020	SELL	$5.12 - $12.22 $51,660 - $123,299	-10,090 Reduced 7.53%	123,956 $1.43 Million
Q3 2019 Oct 31, 2019	BUY	$5.24 - $15.89 $439,840 - $1.33 Million	83,939 Added 167.52%	134,046 $731,000
Q2 2019 Aug 15, 2019	BUY	$5.1 - $11.89 $70,925 - $165,354	13,907 Added 38.42%	50,107 $596,000
Q1 2019 May 03, 2019	SELL	$3.03 - $6.02 $29,360 - $58,333	-9,690 Reduced 21.12%	36,200 $190,000
Q4 2018 Feb 08, 2019	SELL	$2.87 - $5.92 $175,971 - $362,978	-61,314 Reduced 57.19%	45,890 $145,000
Q3 2018 Nov 13, 2018	BUY	$4.5 - $7.6 $319,518 - $539,630	71,004 Added 196.14%	107,204 $649,000
Q1 2018 May 11, 2018	SELL	$3.65 - $7.95 $656,306 - $1.43 Million	-179,810 Reduced 83.24%	36,200 $210,000
Q4 2017 Feb 06, 2018	BUY	$2.85 - $3.95 $64,774 - $89,775	22,728 Added 11.76%	216,010 $756,000
Q3 2017 Nov 15, 2017	BUY	$2.45 - $3.65 $473,540 - $705,479	193,282	193,282 $705,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account